A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 227,078 shares of SLGL stock, worth $145,329. This represents 0.04% of its overall portfolio holdings.

Number of Shares
227,078
Previous 229,178 0.92%
Holding current value
$145,329
Previous $156 Million 35.55%
% of portfolio
0.04%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

SELL
$0.43 - $1.65 $903 - $3,465
-2,100 Reduced 0.92%
227,078 $211 Million
Q3 2023

Oct 30, 2023

BUY
$1.63 - $3.94 $373,560 - $902,961
229,178 New
229,178 $1.18 Million

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $14.8M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Yelin Lapidot Holdings Management Ltd. Portfolio

Follow Yelin Lapidot Holdings Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yelin Lapidot Holdings Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Yelin Lapidot Holdings Management Ltd. with notifications on news.